Latest Security News

Cyprium Metals completed a A$15 million capital raise and formed a strategic alliance with Macmahon to accelerate the restart of its Nifty Copper Complex, while upgrading its Maroochydore copper-cobalt resource.

Genetic Signatures Ltd reported a robust 71% jump in quarterly sales to $2.9 million, fueled by strong respiratory testing demand in Australia and key US commercial contracts. The company is advancing its automation and instrument customisation strategy to streamline molecular diagnostics offerings.

Hydrix Limited reports improved operating performance in Q3 FY25, buoyed by FDA clearance of its Gyder Surgical Hip Navigation system and a reduced cash operating loss, while managing tight liquidity with shareholder support.

West Cobar Metals has identified five high-priority copper-gold targets in Western Australia’s Fraser Range and secured a farm-in deal with Minrex Resources to fund upcoming drilling. Positive metallurgical results at its Bulla Park copper-antimony project and a $450,000 placement underpin its exploration momentum.

Empire Energy Group reported significant cash outflows in Q1 2025 driven by exploration and infrastructure investments but bolstered its liquidity with new financing facilities, including a Midstream Infrastructure Facility for the Carpentaria Gas Plant.

Elixinol Wellness reported a 13.7% year-on-year revenue increase in Q1 FY25, despite a softer quarter compared to record Q4, with ecommerce momentum and strategic initiatives setting the stage for margin recovery and growth in H2.

Empire Energy Group is advancing its Carpentaria-5H well hydraulic stimulation scheduled for June 2025, alongside preparations for the Carpentaria Gas Plant construction, aiming to commence gas sales from EP187 by late 2025 or early 2026.

The Star Entertainment Group reported a 9% revenue decline to $271 million in Q3 FY25 alongside a $21 million EBITDA loss, driven by seasonal factors and operational challenges. The company is advancing strategic investments and joint venture exits amid ongoing liquidity pressures and regulatory hurdles.

Avecho Biotechnology has inked a decade-long exclusive licensing agreement with Sandoz for its pharmaceutical-grade cannabidiol capsule targeting insomnia in Australia, backed by a US$3 million upfront payment and promising milestone and royalty streams.

Lode Resources has reported exceptional high-grade antimony and silver drill results from its Montezuma Project in Tasmania, alongside commencing a substantial 50-60 hole drilling program to expand the deposit.

Vonex Limited has appointed Michael Blake as CEO while completing a $13.9 million entitlement offer and refinancing its debt, reinforcing its operational and financial foundation. The company also earned recognition for industry-leading complaint resolution.

Codeifai Limited reports a robust 141% increase in Q1 2025 cash receipts, driven by its revamped Digital First Engagement First strategy and the expanding ConnectQR SaaS platform. Despite rising costs, the company maintains strong margins and is strategically reviewing its Material Science division.